share_log

Apollomics | 424B3: Prospectus

SEC announcement ·  Apr 25 05:15
Summary by Futu AI
Apollomics Inc., a biopharmaceutical company, has announced a potential offering of up to $200 million in securities, which may include Class A Ordinary Shares, debt securities, rights, warrants, and units. This offering is detailed in a prospectus filed pursuant to Rule 424(b)(3) with the SEC under Registration No. 333-278430. The securities may be offered in various combinations and series, with specific terms to be determined at the time of each offering. A prospectus supplement will provide details about the offering and the securities offered. Apollomics' Class A Ordinary Shares and warrants are listed on the Nasdaq under the symbols 'APLM' and 'APLMW,' respectively. As of April 17, 2024, the closing prices for these shares and warrants were $0.53 and $0.02, respectively. The company's public float...Show More
Apollomics Inc., a biopharmaceutical company, has announced a potential offering of up to $200 million in securities, which may include Class A Ordinary Shares, debt securities, rights, warrants, and units. This offering is detailed in a prospectus filed pursuant to Rule 424(b)(3) with the SEC under Registration No. 333-278430. The securities may be offered in various combinations and series, with specific terms to be determined at the time of each offering. A prospectus supplement will provide details about the offering and the securities offered. Apollomics' Class A Ordinary Shares and warrants are listed on the Nasdaq under the symbols 'APLM' and 'APLMW,' respectively. As of April 17, 2024, the closing prices for these shares and warrants were $0.53 and $0.02, respectively. The company's public float was valued at approximately $58.7 million based on a closing sale price of $0.73 on April 1, 2024. Apollomics is an emerging growth company and a foreign private issuer, which exempts it from certain SEC reporting requirements. The company is incorporated in the Cayman Islands with operations in the U.S. and China through wholly-owned subsidiaries. The offering aims to raise capital for general corporate purposes, which may include working capital, capital expenditures, and potential acquisitions.

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.